论文部分内容阅读
目的:观察红花黄色素和维脑路通治疗脑梗塞的临床治疗效果,为下一步的临床应用提供理论依据。方法:选取我院2009年1月1日—2010年12月31日的脑梗塞住院患者100例,随机平分为A、B两组,A组给予维脑路通治疗,B组在A组基础上加用红花黄色素治疗1个月后观察两组患者的治疗效果,并对结果进行统计分析。结果:A组50例患者,愈合12例,显效14例,有效10例,无效14例,总有效率72.00%;B组50例患者,愈合23例,显效12例,有效12例,无效3例,总有效率94.00%。两组治疗效果比较,差异有统计学意义(P<0.05)。结论:红花黄色素和维脑路通治疗脑梗塞的疗效较好,有一定的临床推广价值。
Objective: To observe the clinical effects of safflor yellow and venlaton in the treatment of cerebral infarction, and provide the theoretical basis for the next clinical application. Methods: A total of 100 hospitalized patients with cerebral infarction from January 1, 2009 to December 31, 2010 were randomly divided into two groups: A and B, group A was treated with Weileuotong, and group B was group A After treatment with safflower yellow for 1 month, the therapeutic effect was observed in both groups, and the results were statistically analyzed. Results: A group of 50 patients, healed in 12 cases, markedly effective in 14 cases, effective in 10 cases, invalid in 14 cases, the total effective rate was 72.00%; B group of 50 patients, healed in 23 cases, markedly effective in 12 cases, effective in 12 cases, invalid 3 For example, the total effective rate 94.00%. The two groups of treatment effect, the difference was statistically significant (P <0.05). Conclusion: Safflower yellow and Venoruton are effective in treating cerebral infarction, and have certain clinical value.